Fagron NV (ENXTBR:FAGR) signed an agreement to acquire Parma Produkt Gyógyszergyártó Korlátolt Felelosségu Társaság in third quarter of 2023. The transaction is subject to fulfillment of customary regulatory approvals expected to
close early January 2024.